Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity and StockBased Compensation (Details 4)

v3.21.2
Stockholders Equity and StockBased Compensation (Details 4) - Options Held [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Shares, non-vested, beginning 49,726 84,873
Shares, Granted 58,164 7,634
Shares, vested 96,124 41,552
Shares, Forfeited 0 1,229
Shares, non-vested, end of period 11,766 49,726
Weighted average exercise price, Beginning $ 9.71 $ 10.73
Weighted average exercise price, granted 6.72 4.45
Weighted average exercise price, vested 8.40 10.80
Weighted average exercise price, forfeited 0 10.80
Weighted average exercise price, end of period 5.71 9.71
Weighted average fair value grant date, beginning 7.44 5.15
Weighted average fair value grant date, granted 2.58 3.28
Weighted average fair value grant date, vested 4.89 8.29
Weighted average fair value grant date, forfeited 0 8.33
Weighted average fair value grant date, end of period $ 4.25 $ 7.44